Inolife: Emerging Leader in Needle-Free Injection Technologies
Sep. 29, 2017
Based in Irvine, CA, Inolife Inc. (OTC: INOL) is an emerging leader in needle free injection technologies. The Company commercializes a patented and FDA-approved needle free injection device under the trademark Inojex30. Inolife is also developing next generation needle free devices and technologies for use in various applications, including diabetes, immunology and analgesia. Inolife’s products are available online at www.inojex.com and through a growing network of distributors globally.
